Insider trades
Fairmount Funds Management, Director of Spyre Therapeutics SYRE, has filed 19 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $846M. The latest trade was on 06/23.
Fairmount Funds Management
Director
- Company
- Spyre Therapeutics SYRE
- First filing
- 23/06/13
- Trades
- 116 trades
- Buys / sales
- 19 / 4
- 12-month net buying
- −$846M
- Last trade
- 06/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 06/23 | 06/23 | 4,684,781 sh | $85.31 | $399,658,667.11 | −100.0% | |
| Open-market buy | 05/11 | 05/13 | 1,176,470 sh | $17.00 | $19,999,990 | +30.1% | |
Zenas BioPharmaZBIO | Open-market buy | 03/31 | 04/01 | 150,000 sh | $20.00 | $3,000,000 | +6.8% |
| Open-market sale | 03/31 | 03/31 | 7,000,000 sh | $34.66 | $242,620,000 | −56.0% | |
| Open-market sale | 01/22 | 01/22 | 3,500,000 sh | $36.40 | $127,400,000 | −38.9% | |
| Open-market sale | 01/22 | 01/22 | 1,750,000 sh | $76.30 | $133,525,000 | −85.4% | |
| Open-market buy | 25/12/04 | 25/12/08 | 1,360,000 sh | $13.41 | $18,237,600 | +98.0% | |
| Open-market buy | 25/10/23 | 25/10/27 | 454,545 sh | $22.00 | $9,999,990 | +13.1% | |
Zenas BioPharmaZBIO | Open-market buy | 25/10/07 | 25/10/09 | 316,219 sh | $19.00 | $6,008,161 | +16.7% |
| Open-market buy | 25/07/10 | 25/07/14 | 2,777,777 sh | $9.00 | $24,999,993 | +44.6% | |
Zenas BioPharmaZBIO | Open-market buyAmendment | 24/09/16 | 24/09/17 | 300,000 sh | $17.00 | $5,100,000 | +18.8% |
| Open-market buy | 24/09/13 | 24/09/17 | 1,600,000 sh | $18.75 | $30,000,000 | +86.7% | |
Zenas BioPharmaZBIO | Open-market buy | 24/09/16 | 24/09/16 | 300,000 sh | $17.00 | $5,100,000 | +23.0% |
| Open-market buy | 24/01/22 | 24/01/24 | 476,190 sh | $21.00 | $9,999,990 | +34.9% | |
| Open-market buy | 23/09/29 | 23/10/03 | 24,670 sh | $13.63 | $336,252.1 | +1.3% | |
| Open-market buy | 23/09/26 | 23/09/28 | 30,000 sh | $13.15 | $394,500 | +1.6% | |
| Open-market buy | 23/09/19 | 23/09/21 | 30,000 sh | $13.20 | $396,000 | +1.6% | |
DNTH | Open-market buy | 23/09/12–23/09/13 | 23/09/13 | 24,254 sh2 trades | $11.20avg. | $271,679.87 | +1.3% |
| Open-market buy | 23/07/13 | 23/07/17 | 2,941,176 sh3 trades | $17.00avg. | $49,999,992 | No record | |
| Open-market buy | 23/06/09 | 23/06/13 | 800,000 sh | $12.00 | $9,600,000 | +32.4% |
